Francisco Dominguez
Santiago, RM, Chile
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Intermediate-Risk Papillary Thyroid Cancer: Not Everyone Needs Radioactive Iodine.
Journal: Clinical endocrinology
Published: March 30, 2026
ThyroidPrint: Thyroid Genetic Classifier Long-Term Follow-Up of Benign Called Lesions.
Journal: Clinical endocrinology
Published: December 17, 2025
Pathologic complete response and survival in early-stage HER2-positive breast cancer patients treated with or without anthracyclines.
Journal: Ecancermedicalscience
Published: October 13, 2025
Melanoma in Chile: demographics and clinico-pathological features.
Journal: Frontiers in oncology
Published: April 01, 2025
Lobectomy in patients with differentiated thyroid cancer: experience of a Chilean tertiary center.
Journal: Endocrine
Published: March 28, 2024
Suboptimal use of ovarian function suppression in very young women with early breast cancer: a real-world data study.
Journal: Breast cancer research and treatment
Published: July 05, 2023
Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients.
Journal: Breast cancer research and treatment
Published: January 16, 2023
ThyroidPrint®: clinical utility for indeterminate thyroid cytology.
Journal: Endocrine-related cancer
Published: December 25, 2022
Clinical characteristics, risk factors, and outcomes in Chilean triple negative breast cancer patients: a real-world study.
Journal: Breast cancer research and treatment
Published: August 16, 2022
Contrast-enhanced mammography predicts pathological response after neoadjuvant chemotherapy in locally advanced breast cancer.
Journal: Ecancermedicalscience
Published: October 23, 2021
Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patients.
Journal: Breast cancer research and treatment
Published: March 12, 2021
Pathological complete response to neoadjuvant chemotherapy, but not the addition of carboplatin, is associated with improved survival in Chilean triple negative breast cancer patients: a report of real world data.
Journal: Ecancermedicalscience
Published: September 08, 2020
Last Updated: 09/26/2026